Related Experiment Video
Updated: Jun 5, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Myofibrillar myopathies
1Department of Neurology, Division of Child Neurology and Neuromuscular Disease Research Laboratory, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA. Selcen.duygu@mayo.edu
Abstract:
Myofibrillar myopathies represent a group of muscular dystrophies with a similar morphologic phenotype. They are characterized by a distinct pathologic pattern of myofibrillar dissolution associated with disintegration of the Z-disk, accumulation of myofibrillar degradation products, and ectopic expression of multiple proteins and sometimes congophilic material. The clinical features of myofibrillar myopathies are more variable. These include progressive muscle weakness, that often involves or begins in distal muscles but limb-girdle or scapuloperoneal distributions can also occur. Cardiomyopathy and peripheral neuropathy are frequent associated features. EMG of the affected muscles reveals myopathic motor unit potentials and abnormal irritability often with myotonic discharges. Rarely, neurogenic motor unit potentials or slow nerve conductions are present. The generic diagnosis of myofibrillar myopathies is based on muscle biopsy findings in frozen sections. To date, all myofibrillar myopathy mutations have been traced to Z-disk-associated proteins, namely, desmin, αB-crystallin, myotilin, ZASP, filamin C and Bag3. However, in the majority of the myofibrillar myopathy patients the disease gene awaits discovery.
Insights
Myofibrillar myopathies are muscular dystrophies causing progressive muscle weakness and often heart or nerve issues. Genetic mutations in Z-disk proteins are implicated, but many disease genes remain undiscovered.
Area of Science:
- Neurology
- Genetics
- Pathology
Background:
- Myofibrillar myopathies (MFMs) are a class of muscular dystrophies defined by specific pathological changes.
- These changes include myofibrillar dissolution, Z-disk disintegration, and accumulation of protein aggregates.
Purpose of the Study:
- To summarize the key characteristics of myofibrillar myopathies.
- To highlight the known genetic underpinnings and identify areas for future research.
Main Methods:
- Review of pathological findings in muscle biopsies.
- Analysis of clinical presentations and associated features.
- Summary of current genetic knowledge regarding MFM mutations.
Main Results:
- MFMs exhibit a consistent pathological pattern but variable clinical phenotypes.
- Common clinical features include progressive muscle weakness (distal, limb-girdle, or scapuloperoneal), cardiomyopathy, and peripheral neuropathy.
- Known mutations affect Z-disk-associated proteins like desmin, αB-crystallin, myotilin, ZASP, filamin C, and Bag3.
Conclusions:
- Diagnosis relies on characteristic muscle biopsy findings.
- While several causative genes are identified, the genetic basis for the majority of MFM cases remains unknown, necessitating further investigation.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone lll
The Sarcomere
Each myosin...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Microscopic Anatomy of Skeletal Muscles
The muscle sarcolemma is a plasma membrane enclosing each muscle cell that conducts electrical signals called action potentials. The sarcolemma extends into the cell to form T-tubules, ensuring the neural impulses are uniformly distributed across the entire muscle...
